180 LIFE SCIENCES CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.87 USD | -6.50% |
|
-4.59% | -53.90% |
| 03-25 | 180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-11 | 180 Life Sciences Corp. Announces Board Changes | CI |
Chart calendar 180 Life Sciences Corp.
6.gCZOtPKfp43SLPLOyTHBQjGnGeXB-41IRStw3P_U5RQ.31UF0aep_sqHfbefo2enM1nLLpWQkeEDKkZJ676OqmLxZXjjodvV-OB-mQ~8233ac6f36665f51d4d78ea5d24afebd
Upcoming events on 180 Life Sciences Corp.
No events available
Past events on 180 Life Sciences Corp.
| 15/02/2024 | Extraordinary Shareholders Meeting |
| 08/07/2023 | Gordon Research Conference |
| 06/07/2023 05:00 | Annual General Meeting |
| 14/12/2022 | Extraordinary Shareholders Meeting |
| 29/11/2022 | A.G.P.’s Virtual Biotech Conference |
| 14/06/2022 17:00 | Annual General Meeting |
| 09/01/2022 | Biotech Virtual Conference |
| 10/12/2021 18:00 | Annual General Meeting |
| 01/12/2021 20:00 | International Dupuytren Symposium |
| 09/09/2021 09:00 | British Society for Surgery of the Hand Meeting |
| 10/08/2021 18:00 | BTIG Virtual Biotechnology Conference |
| 10/06/2021 18:30 | LD Micro Invitational Investor Conference |
| 17/03/2021 13:00 | Maxim Emerging Growth Conference |
| 11/01/2021 11:00 | H.C. Wainwright Bioconnect Conference |
| 15/12/2020 18:40 | LD Micro Main Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -15,6 -15,6 -0.57% | -17,9 -16,5 -8.42% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,9 | -20,3 -25,8 20.98% | 0,00 0,00 - |
|
Net income Million USD | Released Forecast Spread | -10,9 | -20,3 -25,8 21.09% | -38,7 -2,37 -1533.33% |
|
EPS USD | Released Forecast Spread | 0,00 | -247 -308 19.75% | -387 -22,8 -1598.33% |
| Announcement Date | 09/07/21 | 31/03/22 | 31/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -4,46 -4,37 -2.01% | -3,68 -4,34 15.22% | -4,52 -4,53 0.2% | -4,06 -4,41 8.13% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1,03 -4,37 123.54% | 1,56 -4,35 135.97% | 2,94 -4,54 164.8% | -21,5 0,44 -5039.54% |
|
Net income Million USD | Released Forecast Spread | 1,04 -4,37 123.69% | 1,56 -4,35 135.97% | 2,94 -4,54 164.8% | -21,5 0,44 -5039.54% |
|
EPS USD | Released Forecast Spread | 19,0 -49,4 138.46% | 19,0 -49,4 138.46% | 34,2 -49,4 169.23% | -209 3,80 -5600% |
| Announcement Date | 31/03/22 | 16/05/22 | 09/08/22 | 10/11/22 |
More events
Past sector events for 180 Life Sciences Corp.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KBLM Stock
- Calendar 180 Life Sciences Corp.
